Point-of-care testing for cardiac markers: Applications and outcomes

Point of Care

Volumn 7, Issue 4, 2008, Pages 261-265

  Price, Christopher P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiac markers; Creatine kinase; Health outcomes; Myoglobin; Point of care testing; Troponins

Indexed keywords

EID: 67650118128     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e318188bc78     Document Type: Article

References (33)

1. Lau J, Ioannidis JP, Balk EM, et al. Diagnosing acute cardiac ischemia in the emergency department: a systematic review of the accuracy and clinical effect of current technologies. Ann Emerg Med. 2001;37: 453-460.
2. Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ. 2002;324:539-541.
3. Price CP, Christenson RH, eds. Evidence-Based Laboratory Medicine. Washington DC: AACC Press; 2007.
4. Glickman SW, Boulding W, Staelin R, et al. A framework for quality improvement: an analysis of factors responsible for improvement at hospitals participating in the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) quality improvement initiative. Am Heart J. 2007;154:1206-1220.
5. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502-1513.
6. Christenson RH, ed. National Academy of Clinical Biochemistry. Laboratory Medicine Practice Guidelines. Biomarkers of acute coronary syndromes and heart failure. Availabe at http://www.aacc.org/SiteCollectionDocuments/ NACB/LMPG/ACS-PDF-online.pdf. Accessed June 10, 2008.
7. Maisel AS, Templin K, Love M, et al. A prospective study ofan algorithm using cardiac troponin I and myoglobin as adjuncts in the diagnosis of acute myocardial infarction and intermediate coronary syndromes in a veteran's hospital. Clin Cardiol. 2000;23:915-920.
8. Ng SM, Krishnaswamy P, Morissey R, et al. Ninety-minute accelerated critical pathway for chest pain evaluation. Am JCardiol. 2001;88:611-617.
9. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104:1483-1488.
10. Kratz A, Januzzi JL, Lewandrowski KB, et al. Positive predictive value of a point-of-care testing strategy on first-draw specimens for the emergency department-based detection of acute coronary syndromes. Arch Pathol Lab Med. 2002;126:1487-1493.
11. Lee-Lewandrowski E, Corboy D, Lewandrowski K, et al. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med. 2003;127:456-160.
12. Amodio G, Antonelli G, Varraso L, et al. Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department. Coron Artery Dis. 2007;18:181-186.
13. Singer AJ, Ardise J, Gulla J, et al. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann Emerg Med. 2005;45:587-591.
14. Apple FS, Chung AY, Kogut ME, et al. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin Chim Acta. 2006;370:191-195.
15. Motherwell DW, Rogers J, Kellagher M, et al. The introduction of a chest pain nurse and fast-track troponin service reduces the length of stay of patients presenting with chest pain. Scott Med J. 2007;52:6-9.
16. Renaud B, Maison P, Ngako A, et al. Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes. Acad Emerg Med. 2008;15:216-224.
17. Di Serio F, Amodio G, Varraso L, et al. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation. Clin Chem Lab Med. 2005;43:202-209.
18. Di Serio F, Lovero R, Leone M, et al. Integration between the tele-cardiology unit and the central laboratory: methodological and clinical evaluation of point-of-care testing cardiac marker in the ambulance. Clin Chem Lab Med. 2006;44:768-773.
19. Steg PG, Cambou JP, Goldstein P, et al. Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry. Heart. 2006;92:1378-1383.
20. Ishii J, Wang JH, Naruse H, et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem. 1997;43: 1372-1378.
21. Ecollan P, Collet JP, Boon G, et al. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay. Int J Cardiol. 2007;119:349-354.
22. Collinson PO, John C, Lynch S, et al. A prospective randomized controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem. 2004;41:397-404.
23. Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation. 2001;103:1832-1837.
24. McCord J, Nowak RM, Hudson MP, et al. The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome. Ann Emerg Med. 2003;42:343-350.
25. Brown AM, Sease KL, Robey JL, et al. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome. Ann Emerg Med. 2007;49:153-163.
26. Apple FS, Ler R, Chung AY, et al. Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome. Clin Chem. 2006;52:322-325.
27. Apple FS, Murakami MM, Jesse RL, et al. Near-bedside whole-blood cardiac troponin I assay for risk assessment of patients with acute coronary syndromes. Clin Chem. 2002;48:1784-1787.
28. Ordonez-Llanos J, Santalo-Bel M, Merce-Muntanola J, et al. Risk stratification of chest pain patients by point-of-care cardiac troponin T and myoglobin measured in the emergency department. Clin Chim Acta. 2006;365:93-97.
29. Azzazy HM, Christenson RH. Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing? Clin Biochem. 2002;35:13-27.
30. Steg PG, Cambou JP, Goldstein P, et al. Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry. Heart. 2006;92:1378-1383.
31. Kavsak PA, Newman AM, Lustig V, et al. Long-term health outcomes associated with detectable troponin I concentrations. Clin Chem. 2007;53:220-227.
32. Apple FS, Jesse RL, Newby LK, et al. National academy of clinical biochemistry and IFCC Committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem. 2007;53:547-551.
33. Nichols JH, ed. National Academy of Clinical Biochemistry. Laboratory Medicine Practice Guidelines. Evidence-Based Practice for Point-of-Care Testing. Available at http://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/ POCTLMPG.pdf. Accessed June 10, 2008.